14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MATR vs MCHX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Marchex, Inc. Class B (MCHX) is the stronger overall head-to-head candidate over MATR (MATR) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MATR carries a Unified Composite Score of 47.4/100 (HOLD) at $26.23 (N/M Forward P/E, N/A operating margin), whereas MCHX carries 33.8/100 (SELL) at $1.36 (N/M Forward P/E, -3.5% operating margin).
Composite vs. Pillar Nuance: While MATR currently prints a higher short-term Unified Composite Score (47.4/100 HOLD vs. MCHX 33.8/100 SELL), MCHX captures the overall institutional head-to-head verdict (6–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.5% vs. N/A operating margin) and revenue trajectory (+38.7% vs. N/A YoY).
Technical & Structure Timing Caution: MATR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile MCHX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MATR vs MCHX. Trailing 12-month operating profitability (MATR N/A vs MCHX -3.5%) and valuation multiples (MATR N/M vs MCHX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Advertising Agencies value chain with $62.5M market capitalization and -3.5% operating margin.
OpEx & R&D Reinvestment65.0% of Rev ($27M)
90D Engineering Disclosures0 Published
Investor FAQ MATR vs MCHX Key Questions & Quantitative Answers
As of Nov 16, 2026, Marchex, Inc. Class B (MCHX) is the stronger overall head-to-head candidate over MATR (MATR) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MATR carries a Unified Composite Score of 47.4/100 (HOLD) at $26.23 (N/M Forward P/E, N/A operating margin), whereas MCHX carries 33.8/100 (SELL) at $1.36 (N/M Forward P/E, -3.5% operating margin). Composite vs. Pillar Nuance: While MATR currently prints a higher short-term Unified Composite Score (47.4/100 HOLD vs. MCHX 33.8/100 SELL), MCHX captures the overall institutional head-to-head verdict (6–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.5% vs. N/A operating margin) and revenue trajectory (+38.7% vs. N/A YoY). Technical & Structure Timing Caution: MATR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile MCHX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MCHX leads the Growth & Scale pillar: MATR posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MCHX at +38.7% YoY revenue growth and +0.0% YoY earnings growth on $42M TTM revenue (61.5% gross margin, -3.5% operating margin). On trailing 12-month operating scale, MATR generates N/A in USD-normalized revenue versus $42M for MCHX. In operating R&D and SG&A reinvestment, MATR deploys N/A (0 90-day corporate R&D disclosures) versus 65.0% of Rev ($27M) (0 disclosures) for MCHX.
MCHX screens cheaper on headline valuation multiples. MATR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MCHX trades at N/M Forward P/E, N/M Trailing P/E, 21.93x PEG, and 1.5x EV/Revenue (2.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MATR (N/A ROE) versus MCHX (-14.1% ROE) capital efficiency.
In options market volatility and institutional positioning, MATR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 19% Vol realized risk). By comparison, MCHX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 74% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.